KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Gentex (GNTX) EBT (2016 - 2025)

Gentex's EBT history spans 17 years, with the latest figure at $111.4 million for Q4 2025.

  • For Q4 2025, EBT rose 13.92% year-over-year to $111.4 million; the TTM value through Dec 2025 reached $461.1 million, down 2.36%, while the annual FY2025 figure was $461.1 million, 2.36% down from the prior year.
  • EBT reached $111.4 million in Q4 2025 per GNTX's latest filing, down from $120.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $145.5 million in Q3 2024 to a low of $84.8 million in Q2 2022.
  • Average EBT over 5 years is $111.2 million, with a median of $112.5 million recorded in 2025.
  • The largest YoY upside for EBT was 2729.52% in 2021 against a maximum downside of 46.0% in 2021.
  • A 5-year view of EBT shows it stood at $89.4 million in 2021, then rose by 6.81% to $95.5 million in 2022, then skyrocketed by 42.37% to $135.9 million in 2023, then decreased by 28.05% to $97.8 million in 2024, then rose by 13.92% to $111.4 million in 2025.
  • Per Business Quant, the three most recent readings for GNTX's EBT are $111.4 million (Q4 2025), $120.6 million (Q3 2025), and $115.5 million (Q2 2025).